Breaking News Instant updates and real-time market news.

JE

Just Energy

$0.39 /

+0.0016 (+0.41%)

07:16
07/29/20
07/29
07:16
07/29/20
07:16

Just Energy downgraded to Underperform from Sector Perform at RBC Capital

RBC Capital analyst Nelson Ng downgraded Just Energy to Underperform from Sector Perform with an unchanged C$0.30 price target. The analyst believes that the stock will underperform its peers because of elevated debt levels and weak 2021 outlook, as the management has forecast a "material" decline in EBITDA relative to this year after COVID-19 has led to the suspension of all of the company's face-to-face sales channels.

JE Just Energy
$0.39 /

+0.0016 (+0.41%)

07/20/20 Morgan Stanley
Just Energy price target lowered to 80 GBp from 85 GBp at Morgan Stanley
07/10/20 CIBC
Just Energy price target lowered to C$0.50 from C$0.75 at CIBC
07/10/20 RBC Capital
Just Energy price target lowered to C$0.30 from C$1 at RBC Capital
04/13/20 Canaccord
Just Energy price target lowered to C$0.70 from C$1.50 at Canaccord

TODAY'S FREE FLY STORIES

Conference/Events
Dunkin' Brands participates in a conference call with Wolfe Research » 16:53
08/09/20
08/09
16:53
08/09/20
16:53
DNKN

Dunkin' Brands

$68.47 /

+0.4 (+0.59%)

Consumer Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 BofA
Dunkin' Brands upgraded to Buy at BofA on share gain potential
08/03/20 BofA
Dunkin' Brands upgraded to Buy from Neutral at BofA
07/31/20
Fly Intel: Top five analyst upgrades
DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

DNKN Dunkin' Brands
$68.47 /

+0.4 (+0.59%)

Conference/Events
Royal Caribbean participates in a conference call with Wolfe Research » 16:52
08/09/20
08/09
16:52
08/09/20
16:52
RCL

Royal Caribbean

$52.15 /

+1.04 (+2.03%)

Consumer Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 SunTrust
Cruise Line operators downgraded at SunTrust on delayed starting dates
07/14/20 SunTrust
Royal Caribbean downgraded to Hold from Buy at SunTrust
07/14/20 Macquarie
Royal Caribbean downgraded to Neutral from Outperform at Macquarie
RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

RCL Royal Caribbean
$52.15 /

+1.04 (+2.03%)

Conference/Events
Square management to virtually meet with Wolfe Research » 16:50
08/09/20
08/09
16:50
08/09/20
16:50
SQ

Square

$147.21 /

-6.75 (-4.38%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$147.21 /

-6.75 (-4.38%)

SQ Square
$147.21 /

-6.75 (-4.38%)

08/07/20 BMO Capital
Square price target raised to $153 from $116 at BMO Capital
08/06/20 KeyBanc
Square price target raised to $165 from $140 at KeyBanc
08/06/20
Fly Intel: Top five analyst upgrades
08/06/20 Susquehanna
Square price target raised to $180 from $145 at Susquehanna
SQ Square
$147.21 /

-6.75 (-4.38%)

SQ Square
$147.21 /

-6.75 (-4.38%)

SQ Square
$147.21 /

-6.75 (-4.38%)

SQ Square
$147.21 /

-6.75 (-4.38%)

Conference/Events
Alliant Energy management to virtually meet with Guggenheim » 16:48
08/09/20
08/09
16:48
08/09/20
16:48
LNT

Alliant Energy

$54.70 /

+1.31 (+2.45%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNT Alliant Energy
$54.70 /

+1.31 (+2.45%)

LNT Alliant Energy
$54.70 /

+1.31 (+2.45%)

03/16/20 Guggenheim
Alliant Energy upgraded to Buy from Neutral at Guggenheim
02/24/20 Wells Fargo
Alliant Energy price target raised to $65 from $59 at Wells Fargo
12/20/19 Scotiabank
Alliant Energy upgraded to Outperform from Sector Perform at Scotiabank
11/21/19 Barclays
Barclays makes seven rating changes in North America Power & Utilities
LNT Alliant Energy
$54.70 /

+1.31 (+2.45%)

  • 14
    Nov
Conference/Events
Ahold Delhaize management to meet virtually with Wolfe Research » 16:36
08/09/20
08/09
16:36
08/09/20
16:36
ADRNY

Ahold Delhaize

$0.00 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

08/07/20 Berenberg
Ahold Delhaize price target raised to EUR 22.40 from EUR 20.20 at Berenberg
08/06/20 HSBC
Ahold Delhaize downgraded to Hold from Buy at HSBC
06/15/20 Bryan Garnier
Ahold Delhaize downgraded to Neutral from Buy at Bryan Garnier
05/28/20 Wolfe Research
Ahold Delhaize initiated with an Outperform at Wolfe Research
ADRNY Ahold Delhaize
$0.00 /

+ (+0.00%)

Periodicals
Qualcomm lobbying U.S. to sell chips for Huawei 5G phones, WSJ reports » 16:36
08/09/20
08/09
16:36
08/09/20
16:36
QCOM

Qualcomm

$108.26 /

-2.72 (-2.45%)

Qualcomm is lobbying the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

08/03/20 Bernstein
Qualcomm upgraded to Outperform at Bernstein
08/03/20 Bernstein
Qualcomm upgraded to Outperform from Market Perform at Bernstein
07/31/20
Fly Intel: Top five analyst upgrades
07/31/20 Edward Jones
Qualcomm upgraded to Hold on Huawei settlement at Edward Jones
QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

QCOM Qualcomm
$108.26 /

-2.72 (-2.45%)

Hot Stocks
OpGen co-markets COVID-19 antibody test kit » 16:36
08/09/20
08/09
16:36
08/09/20
16:36
OPGN

OpGen

$3.35 /

+1.14 (+51.58%)

As disclosed in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$3.35 /

+1.14 (+51.58%)

OPGN OpGen
$3.35 /

+1.14 (+51.58%)

06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$3.35 /

+1.14 (+51.58%)

Conference/Events
NextEra Energy management to meet virtually with Wolfe Research » 16:35
08/09/20
08/09
16:35
08/09/20
16:35
NEE

NextEra Energy

$287.68 /

+4.805 (+1.70%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEE NextEra Energy
$287.68 /

+4.805 (+1.70%)

NEE NextEra Energy
$287.68 /

+4.805 (+1.70%)

07/29/20 Credit Suisse
Weakness in Bloom Energy shares 'well overdone,' says Credit Suisse
07/27/20 Vertical Research
NextEra Energy upgraded to Hold from Sell at Vertical Research
07/22/20 Credit Suisse
NextEra Energy price target raised to $265 from $252 at Credit Suisse
04/14/20 Morgan Stanley
NextEra Energy downgraded to Equal Weight on valuation at Morgan Stanley
NEE NextEra Energy
$287.68 /

+4.805 (+1.70%)

NEE NextEra Energy
$287.68 /

+4.805 (+1.70%)

Conference/Events
Charles Schwab management to virtually meet with Wolfe Research » 16:35
08/09/20
08/09
16:35
08/09/20
16:35
SCHW

Charles Schwab

$34.03 /

+0.9 (+2.72%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

07/24/20 Morgan Stanley
Morgan Stanley says Schwab share price doesn't reflect TD Ameritrade benefits
07/09/20 Wolfe Research
Charles Schwab upgraded to Peer Perform from Underperform at Wolfe Research
06/08/20 Wolfe Research
TD Ameritrade downgraded to Underperform from Outperform at Wolfe Research
06/08/20 Wolfe Research
Charles Schwab downgraded to Underperform from Outperform at Wolfe Research
SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

SCHW Charles Schwab
$34.03 /

+0.9 (+2.72%)

Periodicals
TikTok planning to sue Trump administration over ban, NPR reports » 16:25
08/09/20
08/09
16:25
08/09/20
16:25
MSFT

Microsoft

$212.45 /

-3.87 (-1.79%)

, TWTR

Twitter

$37.14 /

-0.55 (-1.46%)

TikTok is planning to sue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 SunTrust
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

Periodicals
Twitter expresses interest in buying TikTok's U.S. operations, Reuters reports » 16:17
08/09/20
08/09
16:17
08/09/20
16:17
TWTR

Twitter

$37.14 /

-0.55 (-1.46%)

, MSFT

Microsoft

$212.45 /

-3.87 (-1.79%)

Twitter (TWTR) has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 SunTrust
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

TWTR Twitter
$37.14 /

-0.55 (-1.46%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

MSFT Microsoft
$212.45 /

-3.87 (-1.79%)

Periodicals
Simon Property weighing empty mall spaces as Amazon centers, WSJ says » 16:02
08/09/20
08/09
16:02
08/09/20
16:02
SPG

Simon Property

$62.10 /

+0.89 (+1.45%)

, AMZN

Amazon.com

$3,167.40 /

-54.81 (-1.70%)

, JCP

J.C. Penney

$0.00 /

+ (+0.00%)

, SHLD

Sears

$0.00 /

+ (+0.00%)

Simon Property Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPG Simon Property
$62.10 /

+0.89 (+1.45%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

JCP J.C. Penney
$0.00 /

+ (+0.00%)

SPG Simon Property
$62.10 /

+0.89 (+1.45%)

07/01/20 Goldman Sachs
Simon Property resumed with a Buy at Goldman Sachs
06/18/20 JPMorgan
Simon Property price target lowered to $90 from $145 at JPMorgan
06/17/20 Deutsche Bank
Taubman Centers named short-term sell idea at Deutsche Bank
06/11/20 Deutsche Bank
Simon Property price target raised to $100 from $97 at Deutsche Bank
AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
07/31/20 BMO Capital
Amazon.com price target raised to $3,700 from $3,500 at BMO Capital
07/31/20 RBC Capital
Amazon.com price target raised to $3,800 from $3,300 at RBC Capital
JCP J.C. Penney
$0.00 /

+ (+0.00%)

06/16/20 Guggenheim
Ulta well positioned to capture share as Penny stores close, says Guggenheim
04/16/20 Oppenheimer
Ulta Beauty price target raised to $240 from $220 at Oppenheimer
01/14/20 Oppenheimer
Ulta Beauty price target raised to $310 from $275 at Oppenheimer
11/18/19 Deutsche Bank
Deutsche Bank stays on sidelines despite J.C. Penney's margin gains
SHLD Sears
$0.00 /

+ (+0.00%)

12/24/19 Morgan Stanley
DieHard deal a 'modest positive' for Advance Auto, says Morgan Stanley
SPG Simon Property
$62.10 /

+0.89 (+1.45%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

JCP J.C. Penney
$0.00 /

+ (+0.00%)

SPG Simon Property
$62.10 /

+0.89 (+1.45%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

JCP J.C. Penney
$0.00 /

+ (+0.00%)

SHLD Sears
$0.00 /

+ (+0.00%)

SPG Simon Property
$62.10 /

+0.89 (+1.45%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

JCP J.C. Penney
$0.00 /

+ (+0.00%)

SHLD Sears
$0.00 /

+ (+0.00%)

SPG Simon Property
$62.10 /

+0.89 (+1.45%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

JCP J.C. Penney
$0.00 /

+ (+0.00%)

AMZN Amazon.com
$3,167.40 /

-54.81 (-1.70%)

Hot Stocks
Ellington Financial declares monthly dividend of 9c per common share » 15:33
08/09/20
08/09
15:33
08/09/20
15:33
EFC

Ellington Financial

$12.19 /

+0.185 (+1.54%)

Ellington Financial…

Ellington Financial announced that its Board of Directors has declared a monthly dividend of 9c per common share, payable on September 25, 2020 to stockholders of record as of August 31, 2020. The company also announced its estimated book value per common share of $15.84 as of July 31, 2020. This estimate includes the effect of the previously announced monthly dividend of 9c per common share, payable on August 25, 2020 to holders of record on July 31, 2020, with an ex-dividend date of July 30, 2020.

ShowHide Related Items >><<
EFC Ellington Financial
$12.19 /

+0.185 (+1.54%)

EFC Ellington Financial
$12.19 /

+0.185 (+1.54%)

07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
09/27/19 Nomura Instinet
Ellington Financial initiated with a Buy at Nomura Instinet
EFC Ellington Financial
$12.19 /

+0.185 (+1.54%)

  • 22
    Jan
  • 19
    Nov
Hot Stocks
Majesco enters into amended agreement to be acquired by Thoma Bravo » 15:31
08/09/20
08/09
15:31
08/09/20
15:31
MJCO

Majesco

$13.08 /

+0.045 (+0.35%)

Majesco announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MJCO Majesco
$13.08 /

+0.045 (+0.35%)

MJCO Majesco
$13.08 /

+0.045 (+0.35%)

Hot Stocks
Innovent, Lilly announce interim analysis data from ORIENT-11 » 15:28
08/09/20
08/09
15:28
08/09/20
15:28
LLY

Eli Lilly

$152.89 /

+0.01 (+0.01%)

Innovent Biologics…

Innovent Biologics announced with Eli Lilly that interim analysis data from ORIENT-11 were released in an oral presentation at the IASLC World Conference on Lung Cancer 2020 Virtual Presidential Symposium. This trial was conducted to assess the efficacy of TYVYT in combination with ALIMTA and platinum chemotherapy as a first-line treatment in people with nonsquamous non-small cell lung cancer without sensitive EGFR mutation or ALK rearrangement. ORIENT-11 is a randomized, double-blind, Phase 3 clinical trial evaluating TYVYT or placebo in combination with ALIMTA and platinum chemotherapy as a first-line treatment for advanced or recurrent nsqNSCLC without sensitizing EGFR mutations or ALK rearrangements. Based on the interim analysis conducted by the Independent Data Monitoring Committee, TYVYT in combination with ALIMTA and platinum chemotherapy demonstrated a statistically significant improvement in progression-free survival compared with placebo in combination with ALIMTA and platinum chemotherapy, which met the pre-defined efficacy criteria. After a median follow up of 8.9 months, the median PFS of the sintilimab combination and the placebo combination assessed by the Independent Radiographic Review Committee was 8.9 months and 5.0 months, respectively. The median overall survival was not reached in both groups, but OS showed an improvement favoring the sintilimab combination. Confirmed objective response rate was improved from 29.8% to 51.9%, and the sintilimab combination showed a shorter time to response. The safety profile was consistent with previously reported sintilimab studies, and no new safety signals were identified. National Medical Products Administration of China has accepted the supplemental New Drug Application for this indication.

ShowHide Related Items >><<
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

Conference/Events
Morgan Stanley energy analysts to hold an analyst/industry conference call » 15:26
08/09/20
08/09
15:26
08/09/20
15:26

Global Sustainability…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Bristol-Myers says Opdivo plus Yervoy demonstrates durable survival benefit » 15:19
08/09/20
08/09
15:19
08/09/20
15:19
BMY

Bristol-Myers

$61.03 /

-0.27 (-0.44%)

Bristol Myers Squibb has…

Bristol Myers Squibb has announced that "Opdivo plus Yervoy demonstrated a significant improvement in overall survival in patients with previously untreated, unresectable malignant pleural mesothelioma in the Phase 3 CheckMate -743 clinical trial." With a minimum follow-up of 22 months, treatment with Opdivo plus Yervoy reduced the risk of death by 26%, demonstrating a median OS of 18.1 months versus 14.1 months for platinum-based standard of care chemotherapy. At two years, 41% of patients treated with the Opdivo plus Yervoy combination were alive, compared to 27% of patients treated with chemotherapy. The safety profile of Opdivo plus Yervoy was consistent with previously reported studies, and no new safety signals were observed. Histology is a well-established prognostic factor in mesothelioma, with non-epithelioid patients generally experiencing poorer outcomes. In CheckMate -743, Opdivo plus Yervoy showed improvements in survival across both non-epithelioid and epithelioid MPM, with a larger magnitude of benefit observed in the non-epithelioid subgroup. With the dual immunotherapy combination, median OS was 18.7 months for epithelioid patients and 18.1 months for non-epithelioid patients, compared to 16.5 months and 8.8 months, respectively, with chemotherapy. Opdivo plus Yervoy is a unique combination of two immune checkpoint inhibitors that features a potentially synergistic mechanism of action, targeting two different checkpoints to help destroy tumor cells: Yervoy helps activate and proliferate T cells, while Opdivo helps existing T cells discover the tumor. Some of the T cells stimulated by Yervoy can become memory T cells, which may allow for a long-term immune response.

ShowHide Related Items >><<
BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
07/28/20 Raymond James
Bristol-Myers initiated with an Outperform at Raymond James
BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

BMY Bristol-Myers
$61.03 /

-0.27 (-0.44%)

Initiation
GoHealth initiated with an Outperform at Evercore ISI » 15:12
08/09/20
08/09
15:12
08/09/20
15:12
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Evercore ISI initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

On The Fly
Opening Day: Quicken Loans parent raises only $1.8B in IPO » 08:58
08/09/20
08/09
08:58
08/09/20
08:58
SHOP

Shopify

$1,053.78 /

-34.4 (-3.16%)

, RKT

Rocket Companies

$24.75 /

+3.11 (+14.37%)

, AFIB

Acutus Medical

$27.06 /

+0.21 (+0.78%)

, OSH

Oak Street Health

$39.17 /

-0.06 (-0.15%)

, BIGC

BigCommerce

$78.57 /

-15.19 (-16.20%)

, RXT

Rackspace Technology

$15.42 /

-0.405 (-2.56%)

, HOL

Holicity

$0.00 /

+ (+0.00%)

, CMPI

Checkmate Pharmaceuticals

$14.00 /

+ (+0.00%)

, FRLN

Freeline

$18.00 /

+ (+0.00%)

, IBEX

IBEX

$15.55 /

+ (+0.00%)

, BOWX

BowX Acquisition

$0.00 /

+ (+0.00%)

, GOAC

GO Acquisition

$0.00 /

+ (+0.00%)

, YAC

Yucaipa Acquisition

$0.00 /

+ (+0.00%)

, GRSV

Gores Holdings V

$0.00 /

+ (+0.00%)

, IKT

Inhibikase Therapeutics

$0.00 /

+ (+0.00%)

, BNL

Bunzl plc.

$0.00 /

+ (+0.00%)

Rocket Companies, the…

Open Full Text

ShowHide Related Items >><<
SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

RKT Rocket Companies
$24.75 /

+3.11 (+14.37%)

SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

08/03/20 B. Riley FBR
PFSweb price target raised to $9.50 from $7.50 at B. Riley FBR
07/30/20 Wedbush
Shopify price target raised to $998 from $860 at Wedbush
07/30/20 Wells Fargo
Shopify price target raised to $1000 from $700 at Wells Fargo
07/30/20 DA Davidson
Shopify price target raised to $1,000 from $650 at DA Davidson
RKT Rocket Companies
$24.75 /

+3.11 (+14.37%)

AFIB Acutus Medical
$27.06 /

+0.21 (+0.78%)

OSH Oak Street Health
$39.17 /

-0.06 (-0.15%)

BIGC BigCommerce
$78.57 /

-15.19 (-16.20%)

RXT Rackspace Technology
$15.42 /

-0.405 (-2.56%)

HOL Holicity
$0.00 /

+ (+0.00%)

CMPI Checkmate Pharmaceuticals
$14.00 /

+ (+0.00%)

FRLN Freeline
$18.00 /

+ (+0.00%)

IBEX IBEX
$15.55 /

+ (+0.00%)

BOWX BowX Acquisition
$0.00 /

+ (+0.00%)

GOAC GO Acquisition
$0.00 /

+ (+0.00%)

YAC Yucaipa Acquisition
$0.00 /

+ (+0.00%)

GRSV Gores Holdings V
$0.00 /

+ (+0.00%)

IKT Inhibikase Therapeutics
$0.00 /

+ (+0.00%)

BNL Bunzl plc.
$0.00 /

+ (+0.00%)

SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

  • 06
    Aug
  • 07
    Aug
  • 07
    Aug
  • 06
    Aug
  • 07
    Aug
  • 06
    Aug
  • 05
    Aug
  • 05
    Aug
  • 08
    May
  • 17
    Sep
SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

RKT Rocket Companies
$24.75 /

+3.11 (+14.37%)

SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

RXT Rackspace Technology
$15.42 /

-0.405 (-2.56%)

RKT Rocket Companies
$24.75 /

+3.11 (+14.37%)

SHOP Shopify
$1,053.78 /

-34.4 (-3.16%)

Hot Stocks
ON Semiconductor to explore sale of Niigata manufacturing facility » 16:12
08/08/20
08/08
16:12
08/08/20
16:12
ON

ON Semiconductor

$20.84 /

-0.29 (-1.37%)

ON Semiconductor…

ON Semiconductor announced it is exploring a sale of its manufacturing facility in Niigata, Japan. "The intended sale of Niigata facility is part of the company's plan to optimize its manufacturing footprint and sharpen its focus on highly differentiated power, analog and sensor products. The company will begin searching for strategic buyers to enter into a mutually beneficial arrangement that is expected to facilitate an orderly transition of products from its facility in Niigata to other facilities in its network. The Niigata facility is an automotive qualified facility, which meets the IATF 16949 global industry standard for quality management. The company believes that the facility is an attractive semiconductor manufacturing asset. The site is run by a highly skilled and productive workforce capable of managing a large mix of technologies. The Niigata facility consists of two co-located wafer fabs with 215,000 square feet of clean room space, located on a 40 acre campus with 1.1 million square feet of building space. The large campus, existing infrastructure and capability of eight inch wafer manufacturing provide potential buyers a compelling growth opportunity. Currently, the facility supports the company's BCD, BiCMOS, CMOS, Discrete and Smart Discrete technologies. ON Semiconductor remains committed to growing its presence in Japan, and the company recently added a large eight-inch wafer fab in Aizu to its manufacturing footprint. ON Semiconductor plans to continue to invest in its various functional groups, such as field service, research and development, solution engineering centers, and manufacturing plants to better serve its customers in Japan," the company stated.

ShowHide Related Items >><<
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

07/27/20 Needham
ON Semiconductor price target raised to $26 from $20 at Needham
07/22/20
Fly Intel: Top five analyst upgrades
07/22/20 B. Riley FBR
B. Riley FBR upgrades ON Semiconductor after Texas Instruments beat
07/22/20 B. Riley FBR
ON Semiconductor upgraded to Buy from Neutral at B. Riley FBR
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

Earnings
ON Semiconductor sees Q3 revenue $1.2B-$1.33B, consensus $1.27B » 16:10
08/08/20
08/08
16:10
08/08/20
16:10
ON

ON Semiconductor

$20.84 /

-0.29 (-1.37%)

Based on product booking…

Based on product booking trends, backlog levels, and estimated turns levels, the company anticipates 2020 third quarter revenue to be approximately $1.20B-$1.33B. GAAP and Non GAAP gross margin for third quarter of 2020 is expected to be between 32.0%-34.0%.

ShowHide Related Items >><<
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

07/27/20 Needham
ON Semiconductor price target raised to $26 from $20 at Needham
07/22/20
Fly Intel: Top five analyst upgrades
07/22/20 B. Riley FBR
B. Riley FBR upgrades ON Semiconductor after Texas Instruments beat
07/22/20 B. Riley FBR
ON Semiconductor upgraded to Buy from Neutral at B. Riley FBR
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

Earnings
ON Semiconductor reports Q2 EPS 12c, consensus 2c » 16:09
08/08/20
08/08
16:09
08/08/20
16:09
ON

ON Semiconductor

$20.84 /

-0.29 (-1.37%)

Reports Q2 revenue…

Reports Q2 revenue $1.21B, consensus $1.18B. "Despite disruption from COVID-19 pandemic, we continue to make strong progress towards our key strategic initiatives. To achieve our gross margin target, we have accelerated the pace of manufacturing optimization. In addition, we have made outstanding progress in ramp of our 300mm manufacturing processes at East Fishkill fab with our 300mm wafer production starting in the second quarter, significantly ahead of schedule. With expected decline in COVID-19 related costs and ongoing recovery in global macroeconomic activity, we expect to see sustained improvement in our margins. Our design win pipeline continues to expand rapidly with multiple strategic wins for our power, analog and sensor products in automotive, industrial, and cloud-power applications. We are beginning to see moderate recovery in demand across most end-markets and geographies, and we expect this recovery to continue in near term driven by improving global macroeconomic activity," said Keith Jackson, president and CEO of ON Semiconductor.

ShowHide Related Items >><<
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

07/27/20 Needham
ON Semiconductor price target raised to $26 from $20 at Needham
07/22/20
Fly Intel: Top five analyst upgrades
07/22/20 B. Riley FBR
B. Riley FBR upgrades ON Semiconductor after Texas Instruments beat
07/22/20 B. Riley FBR
ON Semiconductor upgraded to Buy from Neutral at B. Riley FBR
ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

ON ON Semiconductor
$20.84 /

-0.29 (-1.37%)

Conference/Events
SelectQuote participates in a conference call with RBC Capital Markets » 13:30
08/08/20
08/08
13:30
08/08/20
13:30
SLQT

SelectQuote

$20.42 /

+1.365 (+7.16%)

Healthcare Analyst Morgan…

Healthcare Analyst Morgan holds a conference call with CEO Danker & CFO Sadun on August 13 at 2 pm hosted by RBC Capital Markets. Webcast Link

ShowHide Related Items >><<
SLQT SelectQuote
$20.42 /

+1.365 (+7.16%)

SLQT SelectQuote
$20.42 /

+1.365 (+7.16%)

07/01/20 SVB Leerink
SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform
06/30/20 Northland
Benefytt trades at 'large discount' to other MA players, says Northland
06/15/20 Morgan Stanley
SelectQuote initiated with an Equal Weight at Morgan Stanley
06/15/20 Barclays
SelectQuote initiated with an Overweight at Barclays
  • 21
    May
SLQT SelectQuote
$20.42 /

+1.365 (+7.16%)

SLQT SelectQuote
$20.42 /

+1.365 (+7.16%)

Earnings
Berkshire Hathaway buys back $5.1B in Berkshire stock during Q2 » 10:57
08/08/20
08/08
10:57
08/08/20
10:57
BRK.B

Berkshire Hathaway

$209.42 /

+4.32 (+2.11%)

, BRK.A

Berkshire Hathaway

$313,860.00 /

+6238.01 (+2.03%)

Berkshire Hathaway said…

Berkshire Hathaway said in its earnings release that, "Approximately $5.1B was used to repurchase Berkshire shares during the second quarter bringing the six-month total to $6.7B. At June 30, 2020, insurance float - the net liabilities we assume under insurance contracts - was approximately $131B, an increase of $2B since year-end 2019."

ShowHide Related Items >><<
BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

Earnings
Berkshire Hathaway reports Q2 net earnings $26.3B vs. $14.1B last year » 10:55
08/08/20
08/08
10:55
08/08/20
10:55
BRK.B

Berkshire Hathaway

$209.42 /

+4.32 (+2.11%)

, BRK.A

Berkshire Hathaway

$313,860.00 /

+6238.01 (+2.03%)

Berkshire Hathaway…

Berkshire Hathaway reported second quarter net earnings of $26.3B, or $16,314 per Class A share equivalent, from $14.1B, or $8,608 per Class A share equivalent, in the year-earlier period. The company had reported a $49.7B loss in the first quarter. Berkshire noted in its earnings release that, "One unusual item to note occurred during the second quarter: On April 8, 2020, GEICO initiated a $2.5B 'give-back' to policyholders with respect to policies renewed and newly issued policies during the six month period beginning on April 8, 2020. For accounting purposes, the 'give-back' will be spread over the twelve month period beginning on April 8, 2020. The effect was to increase GEICO's underwriting profits during the second quarter that will lead to less favorable results - even perhaps underwriting losses - in the third and fourth quarters."

ShowHide Related Items >><<
BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

BRK.B Berkshire Hathaway
$209.42 /

+4.32 (+2.11%)

BRK.A Berkshire Hathaway
$313,860.00 /

+6238.01 (+2.03%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.